ADVFN - Advanced Financial Network.
HOME» NYSE » N » NVO Stock Price » NVO Stock News

Novo Nordisk a S Share News

 Novo-nordisk a/s (denmark) Stock Price
NVO Stock Price
 Novo-nordisk a/s (denmark) Stock Chart
NVO Stock Chart
 Novo-nordisk a/s (denmark) Stock News
NVO Stock News
 Novo-nordisk a/s (denmark) Company Information
NVO Company Information
 Novo-nordisk a/s (denmark) Stock Trades
NVO Stock Trades

Novo Nordisk May Perform Stock Split - Chief Financial Officer

COPENHAGEN -(Dow Jones)- Danish pharmaceutical company Novo Nordisk A/S (NOVO-B.KO) may perform a stock split in the next couple of years, the company's chief financial officer Jesper Brandgaard said Thursday. "We have done several stock splits over the years, when the price has risen to levels that we found too high. With a price of more than $100, it is something we will consider again," Brandgaard said, speaking after the company released its fourth-quarter results. Novo Nordisk, the world's largest maker of insulin, earlier Thursday reported that its net profit rose 19% on the year in the fourth quarter, to 4.69 billion Danish kroner ($829 million). The result was better than expected, helped by strong growth in sales of its GLP-1 diabetes drug Victoza and ultra-long acting insulin Levemir. -By Flemming Emil Hansen and Niclas Rolander, Dow Jones Newswires; +46-8-5451-3102;

Stock News for Novo Nordisk a S (NVO)
03/27/201513:30:50EUROPE MARKETS: European Stocks Snap Win Streak; DAX Logs First...
03/27/201511:45:14EUROPE MARKETS: European Stocks Set To Snap String Of Weekly...
03/27/201506:59:50EUROPE MARKETS: European Stocks Set To Break String Of Weekly...
03/26/201521:09:30Portfolio Changes For The First Quarter Of 2015
03/26/201514:06:37Report of Foreign Issuer (6-k)
03/26/201507:56:57Novo's faster-acting insulin matches NovoRapid
03/26/201506:21:51Report of Foreign Issuer (6-k)
03/25/201507:16:06Report of Foreign Issuer (6-k)
03/24/201508:40:14Bristol-Myers Squibb nabs exclusive license for autoimmune diseases...
03/24/201506:28:17Report of Foreign Issuer (6-k)
03/24/201502:46:05Novo Nordisk Gets EU Marketing Approval for Obesity Treatment
03/23/201509:16:34Report of Foreign Issuer (6-k)
03/22/201503:13:16I'll Take Some Greenblatt With A Touch Of Domash
03/20/201509:45:38Report of Foreign Issuer (6-k)
03/18/201519:52:16Novo Nordisk Is In The NASH Space, Too
03/16/201510:04:27Report of Foreign Issuer (6-k)
03/15/201518:10:25Dividend Contenders: 26 Increases Expected In The Next 11 Weeks
03/13/201508:18:415 High Quality European Dividend Payers
03/10/201502:21:06Novo Nordisk Readies For Saxenda Launch - Investors Need To Keep...
03/09/201508:41:45Report of Foreign Issuer (6-k)

Novo Nordisk a S and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations